This article is in response to the challenge issued to the scientific community by the National Toxicology Program to predict the carcinogenicity potential of 30 
Introduction
A formidable challenge among health professionals centers on the ability to predict, with reasonable accuracy, toxicologic and carcinogenic activities of exposure circumstances without actually having to conduct experimental research deemed necessary and essential to identify human health hazards. Humans and most other species are exposed to a plethora of both natural and synthetic chemicals in myriad, complex, and matrixal compositions (1, 2) . Unfortunately, most risk assessments are done on single entities that typically have little to do with real exposures. Most of these assessments come historically from experimental carcinogenicity studies and testing on single chemicals (3) . Both now and in the future, more emphasis must be given to studying both simple and complex mixtures, as well as consumer, environmental (e.g., home), and occupational and workplace exposure circumstances (4) .
In this article, we are responding to the challenge of the National Toxicology Program (NTP) to the scientific community to predict the carcinogenicity potential of 30 chemicals currently being tested by the NTP. Our predictions (read, "educated estimates or guesses") are based on available data on other chemicals and short term testing data on the 30 chemicals. Much of our educated estimating or guessing involved what we know already about other chemicals or metabolites that have been tested. These data include structureactivity relationships, physical and chemical properties, classes of agents (e.g., nitrosamines, aromatic amines, anthraquinones, and others known to be carcinogenic); mutagenicity and genetic toxicity; metabolic activation to reactive molecules (e.g., epoxides); mechanisms of carcinogenesis, and preneoplastic or neoplastic indicators identified in shorter term toxicity experiments. These criteria have been summarized, most notably by Weisburger (5), Fung et al. (6) , and Woo et al. (7) .
The newest entry into this prediction melange is mechanism (8) (9) (10) (11) (12) ); yet mechanisms of carcinogenesis, albeit exciting, remain virtually futuristic and must receive continuing study and verification before acceptance into the scientific, regulatory, and legislative complex (13) (14) (15) . Unfortunately this has happened already.
We also include in this article the predictions of the National Cancer Institute (NCI) Chemical Selection Working Group (CSWG), which nominated 25 of the 30 chemicals for carcinogenicity testing. The CSWG has been in existence since the early 1970s. It is an interagency group of federal scientists that currently operates under the auspices of the Chemical and Physical Carcinogenesis Branch, Division of Cancer Biology, NCI. The CSWG serves as an evaluation committee in the NCI chemical selection process for nominating chemicals for carcinogenicity and other toxicity testing; reported to the NCI before 1978, and since then to the NTP. Because the CSWG's predictions were based on a much smaller database than that available to the current predictors, we thought it would be interesting to compare the success of the CSWG's predictive rate with that of the other participants in the NTP challenge exercise.
We surmise that one of the reasons for this challenge exercise is to determine how good the various predictive methodologies are and their potential for replacing the bioassay. Therefore, we thought it would be remiss not to emphasize that the bioassay is still the best way to ascertain whether a chemical is carcinogenic in rodents and that it would be unwise to decide against testing based on information from shortterm studies. Accordingly, in the discussion section we provide examples of chemicals that were found to be carcinogenic in bioassays but for which there were no suggestions of carcinogenic activity in the short-term studies, and chemicals that were found to be noncarcinogenic but for which there were suggestions of carcinogenicity potential from the short-term studies.
Methods
In addition to the comments in the preceding paragraph, many computerized methods are currently used for predicting Environmental Health Perspectives -Vol 104, Supplement 5 * October 1996 carcinogenic potential of agents not yet tested. In a previous NTP challenge exercise on 44 chemicals being tested, the most successful predictive rate was reported to be that of "human experts" (16) (17) (18) . Not surprising, the ability of computer models to predict carcinogenicity can only be as good as the dataset on which each method was based. As we have learned and were prepared for in advance, it is exceedingly difficult to create machine/computer methods that incorporate all the various factors and biological modalities and idiosyncrasies that need to be considered in predicting carcinogenicity of chemicals (4, 14) .
So far, of the computer models available, the U.S. Environmental Protection Agency's Expert Oncologic System appears to come closest to bringing together the parameters used typically by a human expert.
Further, if one does concentrate on computer-prediction models, one should remain critical of results that may be contrary to established scientific thought; that is, computers are often wrong. Thus, it is clear that computer predictions should be scrutinized by human experts regarding both logical and scientific sense. Obviously, then, there is still a vital need for scientific intuition that is lacking in computerized models. With this in mind, and calling ourselves human experts, we attempted to utilize the totality-of-information approach to predict the potential carcinogenicity of 30 chemicals that are currently being tested or whose long-term studies were recently completed. Our predictions are based mainly on the criteria briefly mentioned above and described in more detail below, and on our scientific intuition-or naivete-when there are insufficient or inadequate data available.
The criteria used to assign suspicion of carcinogenicity to a chemical included * positive or suggestive results from previous experimental studies in animals or epidemiological studies * close structural relationship to known carcinogens or chemical classes of carcinogens * potential to act directly as an electrophilic agent or to be metabolized to an electrophilic species * potential to act as a DNA intercalating agent * potential to be metabolized to active free radical species * positive results from mutagenicity studies (e.g., in Salmonella typhimurium). Information on the absorption, distribution, metabolism and excretion of chemicals was also considered in the evaluation of the carcinogenic potential of the candidate chemicals. Thus, physical properties such as solubility in water and organic solvents; partition coefficients; and vapor pressure, which impact on the bioavailability of the chemicals were also given consideration.
For some chemicals, we elected to predict equivocal results because both toxic and detoxication mechanisms may be operative, and we were not able to estimate which would be the dominant mechanism.
Results
At the time of nominating and selecting chemicals for toxicologic characterization, including carcinogenesis, the CSWG typically rendered a guess-or prediction-for carcinogenic potential of the selected chemical. The CSWG's predictions were based on the criteria described above; however, at the time of doing this there was very little or no biologic or toxicologic information available on these chemicals. Table 1 lists the 30 chemicals and the CSWG's predictions: The CSWG did not evaluate 5 of the chemicals and therefore recorded no judgment on them; for the remaining 25, 16 were predicted to be carcinogenic (64%), 8 were considered unknown (32%), and one (xylenesulfonic acid, sodium) was considered to be noncarcinogenic (4%). Obviously this reflects the policy, which was prevalent at that time, of selecting and testing chemicals most likely to present carcinogenic risks to humans (6, 19) .
Nearly two decades later, on the basis of our intuitive sense and experience in evaluating chemicals for carcinogenic activity, and the availability of much more biologic and toxicologic information, we believe 16 of the 30 chemicals (53%) would be carcinogenic to one or more of the experimental groups configured in the typical two-species bioassay (3, 4, 20) ; 4 of the 30 chemicals (13%) would be noncarcinogenic, and 10 (33%) would be equivocal or weakly carcinogenic (Table 1 ). The three tabular columns contain the alphabetical listing of chemicals, with CAS registry numbers and the route of exposure; our predictions together with the rationale for this decision, as well as supplementary decision making comments; and the historic CSWG earlier predictions.
For several of these chemicals our placement into a particular category was more certain than for others. Some predictions were particularly difficult and represent real or significant guesses. In a few cases, disagreement among us remains; and these received consensus based on compromise and majority rules. For these few, we await the test results to learn who was the correct predictor.
We attempted initially to predict carcinogenic potential of these chemicals by individual species, strain, and gender: male rats, female rats, male mice, female mice. This proved to be unsatisfactory to us and was abandoned, for the most part, as being particularly fanciful. Thus, except where specified, our predictions are given on a chemical basis and not on each of the four individual experimental test units within that chemical bioassay. In certain instances we thought to follow various indicators (e.g., aliphatic solvents typically cause liver tumors in mice and perhaps kidney tumors in male rats) gleaned from previous bioassays, but even with these cases we decided this would be frivolous.
Discussion and Conclusions
In our view, except in rare cases these predictions, while being intellectually interesting and enjoyable, do not and likely will not replace eventual in vivo testing (2, 4, 6, 14, 19, 21, 22) . We offer here a few examples of chemicals that were tested although there was no way to anticipate the results. No one predicted that phthalates (di-2-ethylhexyl phthalate) would be carcinogenic in long-term exposure studies (23) (24) (25) ; however, the findings of carcinogenicity for the phthalates led to a large research effort directed toward mechanistic relevance of chemicals causing peroxisome proliferation. We were reproved for testing, among other chemicals, d-limonene; yet this oil-of-orange induced tumors of the kidneys in male rats (26) , concomitantly associated with a testoster one-stimulated protein (@i2p globulin) that purportedly plays some mechanistic role in this lesion (27) (28) (29) (30) (31) . Again these testing results-as well as findings for unleaded gasoline-stimulated much research into mechanisms. Also, so-called nongenotoxic carcinogens (32) identified in long-term bioassays have generated much speculation and hypotheses into mechanisms. Both di-2-ethylhexyl phthalate and d-limonene are nongenotoxic; hence other mechanisms are sought for their activity.
Much of this effort centers on the association or lack thereof of chemically induced toxic lesions leading to or progressing to benign and malignant tumors. Most large studies find little or no correlation or consistency between toxicity and carcinogenicity (28, 33, 34) . Often empirical completed; yet little is reported about the myriad times no correlations could be made for these same observations. Another example is organ specific DNA adduct formation. This biomarker was highly valued as a predictor of carcinogenesis until more numerous findings showed organs exhibiting cancer but no adduct formation, and organs showing DNA adducts but no cancer. One of the values, of course, is as a biomarker measure of exposure, which may prove to be the purpose of induced hyaline droplets or a2.-globulin.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) may be the one chemical that caused the largest avalanche of mechanistic research in a continuing effort to discover and explain why or how this nonmutagenic (37) carcinogen was positive in the carcinogenesis bioassay (38) (39) (40) . Clearly much of this research may have been stimulated by the Seveso accident in 1976 (41) (42) (43) . Decades later, however, we remain uncertain about the mechanism(s) of carcinogenesis of TCDD (44, 45) , or for any other chemical carcinogen.
Even when we and others (46) decided to test benzene, we were challenged because everyone "knew already" that benzene caused leukemia in humans, and previous in vivo tests in animals failed to show carcinogenic activity (47, 48) ; thus the following question was raised. why test this chemical again and waste further time, more money, and scarce facilities on a "known" negative? Yet the major thrust was not only to determine if indeed benzene would be carcinogenic in more modern and adequately designed protocols, but also if this clastogenic human carcinogen would be detected in our rodent models and hence would tend to further validate these models. Despite the many previous negative (and largely inadequate) studies on benzene, this chemical was considered "quite" carcinogenic in our test systems (49, 50) . Predictions at the time thus centered on a negative outcome.
Another example of a known human carcinogen, and a so far marginal-evidence carcinogen in rodents is arsenic. After many years of attempting to have this metal tested in the NTP protocol, the bioassay is now being designed under the rubric of mechanistic studies. The point here is that some still insist that the bioassay is not relevant to humans simply because this single human carcinogen has not been shown to be a potent or convincing carcinogen in rodents. Few mention that the studies done till now have been woefully inadequate (51, 52) . Nonetheless, we wonder, if inorganic arsenic were on this exercise list of 30 chemicals, how many of the participants would place it in the carcinogen category.
Another interesting and controversial example is trichloroethylene (TCE), a highvolume solvent and degreaser once used to decaffeinate coffee. When the first test results were made available in 1976, the studies caused considerable debate because some charged that the TCE-induced carcinogenicity was due to or influenced by a small amount of epichlorohydrin used as a stabilizer in the commercial product. First, TCE was not predicted to cause cancer in laboratory animals; and second, the pattern of tumors was different from that seen with epichlorohydrin alone. Nonetheless, TCE (without epichlorohydrin) was retested, and shown again to be carcinogenic. Now we learn that TCE has been shown to cause kidney cancer in humans (53), a site common to that seen previously in animals. This was the first in a long series of short-chain halogenated aliphatic hydrocarbon solvents shown to consistently cause tumors in laboratory animals. Without knowing all this information, we suspect TCE would be predicted not to be carcinogenic. Ironically, TCE was replaced with another short-chain halogenated aliphatic hydrocarbon, methylene chloride, in decaffeinated coffee (54) .
On the other hand, and using what we know already about empirical or qualitative chemical carcinogenesis, we have more predictive conviction on certain chemicals or classes of chemicals. For instance, we believe no other benzidine-based dyes, nitrosamines, aminoanthraquinone pigments, phenylenediamines, anilines, or benzo[x]pyrenes, among others, need be tested for carcinogenicity. That is, for these groups or classes of chemicals, should we not assume with some degree of scientific confidence that such chemicals would be carcinogenic, and not bother with confirmatory long-term studies? Of course exceptions do and will exist, but perhaps the producers, or sellers of a new aminoanthraquinone dye, for example, should be obligated to prove noncarcinogenicity before marketing, rather than force others to prove carcinogenic activity.
Even in these situations one must be receptive to contradictions. We felt almost obligated to predict that emodin (an anthraquinone) would not possess any carcinogenic activity or would simply give a marginal or equivocal tumor response; we reached this conclusion because emodin, although mutagenic to Salmonella, is 1, 3, 8-trihydroxy-6-methyl anthraquinone that ostensibly would be easily and rapidly metabolized, conjugated, and excreted. The more we thought about this, and with the awareness that 1-hydroxyanthraquinone; 1,8-dihydroxyanthraquinone; and 1,2,4-trihydroxyanthraquinone are each carcinogenic, often with different target organs, we elected to place emodin in the anthraquinone-carcinogen category. Our original predisposition was diverted with information that we thought was more important and relevant.
Conversely, from the beginning, we thought that the parent to this class of chemicals, anthraquinone, would be carcinogenic based largely on prechronic toxic and proliferative effects (which mimicked substituted anthraquinones shown to be carcinogenic), positive mutagenicity findings, and in vivo micronuclei induction. However, we decidedly placed more importance on the likelihood of rapid metabolism and elimination via 2-hydroxyanthraquinone rather than on the shorter term toxicity test results. Further, we hypothesized that the observed carcinogenic activity of the 1-and 8-hydroxyanthraquinones may be due to formation of a pyrene-type structure via hydrogen bonding between the hydroxyl and carbonyl functions. Formation of this structural moiety is not possible for 2-hydroxyanthraquinone, and thus we predicted that anthraquinone would not be carcinogenic. Whether this turns out as we predict awaits the real data.
Scopolamine, a naturally occurring tropane alkaloidal anticholinergic chemical, proved moderately difficult to predict. It was virtually devoid of mutagenic activity in a battery of in vitro (except weakly positive for chromosomal aberrations in CHO cells with activation) and in vivo assays (the mouse peripheral blood micronucleus test). It is rapidly absorbed (bioavailability = 20-30%), and excreted (t1/2 = 3 hrs). The CSWG predicted a carcinogenic response because scopolamine contains an aliphatic epoxide moiety and potential for nitrosation of the amino group. Yet, none of the short-term tests revealed mutagenic or alkylating activity. No toxicology was observed in 16-day or 14-week studies. Also, it is possible that the epoxide may not be reactive due to its hindered location. Nonetheless, because of this structural alert we placed this agent in the marginal or equivocal, borderline-tonone, category.
At present, and for a relatively long history, the most certain method by which to identify potential human carcinogens comes from exposing laboratory animals to particular exposure circumstances similar to those of humans-chemical, mixtures of chemicals, occupations, work places, lifestyles, personal habits, environmental conditions, and combinations of these for long periods. Perhaps some day, human expert-computer-machine learning interactive methods will become more adept, proficient, and accurate at utilizing minimal or no available information to predict which exposures will be carcinogenic, and which of those will then most likely represent the greatest carcinogenic risks to exposed populations. These and other in vitro and in vivo alternatives have been searched for over the decades, with some, albeit limited, success for complementing the bioassay. None, however, have been considered successful enough, in our view, to replace or in most cases even reduce reliance on the long-term bioassay. Some methods have striven to simply shorten the exposure times by developing in vivo assays whereby select initiators have been used (55) .
Despite these noble attempts, the current bioassay, with its recognized faults and shortcomings, has survived both valued and misguided criticisms to discredit its worthiness and reliability as well as balanced scientific and public health-based Environmental Health Perspectives -Vol 104, Supplement 5 * October 1996 0li efforts to replace, reduce, refine, or eliminate the use of and dependence on it.
We hope that new methods will be developed that can eventually replace the current bioassay. These methods should be quicker and less expensive than the current bioassays, and should use few or no animals, and be fully predictive of effects in humans. Meanwhile, and to best protect public health, exposure circumstances should be evaluated at an increasing pace using in vivo long-term bioassays.
